Optiver Holding B.V.

Position in SNY — Sanofi

CIK 1859606 AMSTERDAM, P7

Position in SNY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,938,364

-$18,854,317 QoQ

Shares Held

115,761

-76.6% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#120

of 712 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. SNY ranks #2 (18.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	90,150	$17,094,243
2	SNY	Sanofi This page	115,761	$4,938,364
3	NVO	Novo Nordisk A S	47,719	$2,287,648
4	GSK	GSK plc	15,941	$835,627
5	AMGN	Amgen Inc	1,448	$524,349
6	GILD	Gilead Sciences, Inc.	1,941	$245,225
7	PFE	Pfizer Inc	7,242	$174,387
8	BMY	Bristol Myers Squibb Co	2,302	$132,641

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,938,364	115,761	-76.6%	Shares	Defined	2026-08-12
2026-03-31	$23,792,681	493,829	+44.0%	Shares	Defined	2026-05-15
2025-12-31	$16,619,357	342,950	-29.2%	Shares	Defined	2026-02-17
2025-09-30	$22,858,440	484,289	-1.7%	Shares	Defined	2025-11-10
2025-06-30	$23,803,689	492,728	+261.0%	Shares	Defined	2025-08-14
2025-03-31	$7,570,511	136,504	+114.6%	Shares	Defined	2025-05-15
2024-12-31	$3,067,669	63,605	-86.9%	Shares	Defined	2025-02-14
2024-09-30	$28,079,295	487,234	+109.1%	Shares	Defined	2024-11-14
2023-09-30	$12,499,139	233,019	-67.5%	Shares	Defined	2023-11-13
2023-06-30	$38,625,818	716,620	+76.1%	Shares	Defined	2023-08-10
2023-03-31	$22,147,361	406,971	+288.8%	Shares	Defined	2023-05-11
2022-12-31	$5,069,410	104,675	+39.7%	Shares	Defined	2023-02-10
2022-09-30	$2,849,180	74,939	+0.9%	Shares	Defined	2022-11-14
2022-06-30	$3,714,177	74,239	+81.9%	Shares	Defined	2022-08-10
2021-12-31	$2,044,631	40,811	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.